Recent revelations by pharmaceutical company AstraZeneca have brought Covid vaccines back into the spotlight, with acknowledgment that its AstraZeneca-Oxford vaccine can, in very rare instances, lead to Thrombosis Thrombocytopenia Syndrome (TTS)," a condition involving the formation of blood clots in blood vessels. Despite these rare occurrences, the pharmaceutical firm maintains that extensive clinical trial data and real-world evidence consistently support the safety and effectiveness of the vaccine. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
